glp 1 drug shortage GLP-1 = Over GLP-1 Drugs Mounjaro, Zepbound, Wegovy

Macrophage activation in human diseases

It remains investigational

doi: 10.1038/s41598-019-52103-x 12 AbdalqadirNAdeliK

In STEP 1, patients with obesity (without diabetes) lost nearly 15% of body weight on weekly semaglutide

But Thissen recommends reframing it as a stepping stone towards future health, so patients can get their kickstart and develop healthy habits, so they lose the weight and dont regain it. Patients with smaller weight loss goals, Thissen adds, can consider using a lower-than-standard dose, something often called microdosing on social media

Although there have been no specific trials to show cardiorenal benefit for GLP-1RA or SGLT2i when used as first-line therapy or as monotherapy or in newly diagnosed T2D, the benefit seen in the CV outcome trials has not been found to vary with the duration of diabetes, suggesting that similar benefits might be seen early in the course of disease.4 The benefits are also not dependent on the presence of metformin